Welcome to our dedicated page for F5 SEC filings (Ticker: FFIV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on F5's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into F5's regulatory disclosures and financial reporting.
F5, Inc. filed a Form 144 notice indicating a proposed sale of 5,297 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an approximate sale date of 08/11/2025. The filing lists an aggregate market value of $1,706,874.03 and shows 57,447,170 shares outstanding, indicating the proposed sale is a small portion of the company's total shares.
The shares were acquired as restricted stock from the issuer on 08/01/2018 and payment is recorded as on that date. The filer reports no securities sold in the past three months and makes the standard representation that they do not possess undisclosed material information; the filing references Rule 10b5-1 language but does not provide a plan adoption date.
FFIV Q3 FY25 (quarter ended 30 Jun 2025) snapshot:
- Revenue $780.4 m, +12% YoY; product $388.8 m (+26%), services $391.5 m (+1%).
- Gross margin 81.0% (+60 bp); operating margin 25.2% (+180 bp).
- Net income $189.9 m (+32%); diluted EPS $3.25 (+33%).
- Nine-month operating cash flow $741.6 m; cash & investments $1.43 bn (up $359 m since 9/24); no debt after $350 m revolver expired 1/31/25.
- Deferred revenue grew to $1.96 bn (+9% vs 9/24); RPO $2.0 bn with 61% due within 12 months.
- Share buy-backs: 0.49 m shares for $125 m; $1.05 bn capacity remains.
- Systems revenue rebounded (+39%) and now 46.5% of product mix; software +16%.
- OpEx +10% YoY (R&D +10%, G&A +19%); FY25 YTD restructuring charges $11.3 m.
- Effective tax rate fell to 10.8% (vs 16.0%); diluted share count -1.1% YoY.
Balance sheet strong: assets $6.11 bn, long-term liabilities $1.09 bn, equity $3.47 bn. Two immaterial acquisitions added $12 m goodwill; no impairment or credit issues disclosed.